Items where SHU Author is "Reynolds, Gavin"
|Up a level|
Jump to: Article
Number of items: 8.
TANG, Hao, DALTON, Caroline, SRISAWAT, Umarat, ZHANG, Zhi Jun and REYNOLDS, Gavin (2014). Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia. The International Journal of Neuropsychopharmacology, 17 (04), 645-649.
MCKIBBEN, C. E., REYNOLDS, Gavin and JENKINS, T. A. (2014). Analysis of sociability and preference for social novelty in the acute and subchronic phencyclidine rat. Journal of Psychopharmacology, 28 (10), 955-963.
LIM, C H, ZAIN, S M, REYNOLDS, Gavin, ZAIN, M A, ROFFEEI, S N, ZAINAL, N Z, KANAGASUNDRAM, S and MOHAMED, Z (2014). Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 54, 157-162.
TANG, H, MCGOWAN, O O and REYNOLDS, Gavin (2014). Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action. Pharmacogenomics, 15 (12), 1599-1609.
REYNOLDS, Lindsay M. and REYNOLDS, Gavin (2011). Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder. Journal of Psychiatric Research, 45 (1), 54-59.
GLYNN, Dervila, GIBSON, Helen E., HARTE, Michael K., REIM, Kerstin, JONES, Susan, REYNOLDS, Gavin and MORTON, A. Jennifer (2010). Clorgyline-mediated reversal of neurological deficits in a Complexin 2 knockout mouse. Human Molecular Genetics, 19 (17), 3402-3412.
REYNOLDS, Gavin and KIRK, S.L. (2010). Metabolic side effects of antipsychotic drug treatment : pharmacological mechanisms. Pharmacology and Therapeutics, 125 (1), 169-179.
YEVTUSHEKO, Olga O., COOPER, Stephen J., O'NEILL, Ryan, DOHERTY, Jennifer K., WOODSIDE, Jayne V. and REYNOLDS, Gavin (2008). Influence of 5-HT2c receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. British Journal of Psychiatry, 192 (6), 424-428.